14.02.2018 20:30:00

Safe Rx adds Sales and Marketing Executives Andy Cipra & Rick Meckstroth

GREENWOOD VILLAGE, Colo., Feb. 14, 2018 /PRNewswire/ -- Safe Rx LLC is announcing the appointment of Andy Cipra to the role of Chief Commercial Officer and Rick Meckstroth to Vice President of Business Development.  

www.safe-rx.com

Mr. Cipra & Mr. Meckstroth combined have over 60 years of sales, marketing and product development experience at large companies including 3M and Procter & Gamble while also driving growth in smaller, private companies and venture backed startups.

"These new additions to our senior team position us to manage significant growth as we roll out LPV dispensing to protect American communities and families from the risk of addiction," said Milton Cohen, President & CEO.

Mr. Cipra most recently served as Chief Commercial Officer for MedAvail Technologies and VP Marketing for DISH Network.  Prior to that he led billion dollar brands at P&G including Iams Pet food and Vicks NyQuil, DayQuil and VapoRub.  Andy is a classically trained marketer and proven business leader.

"We are at a critical national crossroads in fighting the opioid epidemic, and I look forward to helping create the new standard for safe prescription packaging and dispensing as part of the Safe Rx team.  The idea behind Safe Rx is simple and the impact we can have on saving lives is profound," said Mr. Cipra. 

Mr. Meckstroth is a senior sales and marketing executive with over 35 years of experience in personal health care and pharmaceuticals.  He spent 30 years with Procter & Gamble in a variety of leadership positions in both domestic and global business units.  He will be leading the expansion of the product to pharmacies and health systems.

Prescription drugs are the number one gateway to heroin addiction and the most commonly abused substances among 12 and 13-year-olds, with pilfering from family medicine cabinets the number one source for teen abuse. Designed to prevent pilfering, Safe Rx® LPVsTM represent the first improvement to secure packaging for prescription drug dispensing since 1970, when the Poison Prevention Packaging Act established child resistant standards. 

About Safe Rx® LPVsTM
Safe Rx® LPVsTMare physician-developed, child resistant certified locking prescription vials that are tamper-evident and pilfer-resistant.  Designed for use in high volume dispensing, Safe Rx® LPVsTM are engineered for extremely low incremental fill time and easy workflow adaptation.  For more information visit www.safe-rx.com.

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/safe-rx-adds-sales-and-marketing-executives-andy-cipra--rick-meckstroth-300598847.html

SOURCE Safe Rx

Analysen zu Nu Skin Enterprises Inc. Amehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Nu Skin Enterprises Inc. A 7,20 -0,69% Nu Skin Enterprises Inc. A